Search
for
Sort by
Research 30 of 1000+
- 170 Forecasting Phase 3 Dose-Response for Abrocitinib, an Oral Janus Kinase 1 Selective Inhibitor, Using Investigator’s Global Assessment and Eczema Area and Severity Index
- Facial Psoriasis Log-based Area and Severity Index: A valid and reliable severity measurement method detecting improvement of facial psoriasis in clinical practice settings
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- Psychological assessment in 355 Chinese college students with androgenetic alopecia
- A new classification of early female pattern hair loss
- BH04 Review of a dermatology nurse-led hair service
- Long‐Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real‐World Multicentric Case Series
- 15485 Evaluating the safety and efficacy of intense pulsed light with radiofrequency in US patients with hidradenitis suppurativa: A split-body study
- Dupilumab for prurigo nodularis: real-world outcomes up to 104 weeks from the Dupilumab Italian Prurigo Nodularis (DUPItaPN) study
- Frontal fibrosing alopecia
- Phototherapy with Topical Minoxidil in Vitiligo: A Randomized Control Trial
- Lichen Planus Activity and Damage Index (LiPADI)–Creation of the Questionnaire
- Validity And Reliability of The Thai Version of The Family Dermatology Life Quality Index
- ASSESSMENT OF THE SEVERETY OF ANDROGENETIC ALOPECIA USING TRICHOSCOPIC FEATURES AND THEIR CORRELATION WITH HISTOMORPHOLOGICAL FINDINGS
- Scoring systems for pemphigus
- Oral tofacitinib for recalcitrant lichen planus pigmentosus: A hospital-based retrospective study
- Effectiveness of Aesthetic Surgical Procedures on Body Image and Psychological Health in Pakistan
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- STRIAA (Severity TRichoscopy Index Alopecia Areata): Validation of a Novel Trichoscopic Tool for Evaluation of Alopecia Areata
- The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Serum level of Apelin-12 in acne patients: Is it a marker of disease severity?
- Validation of the Cutaneous Lupus Disease Area and Severity Index (CLASI) using physician- and patient-assessed health outcome measures
- Serum Vitamin D Levels and Severity of Male Androgenetic Alopecia in North Sulawesi: A Cross-Sectional Study
- A pilot study of 2% tofacitinib cream with narrowband ultraviolet B for the treatment of facial vitiligo
- A prospective, interventional, randomized, open-label, comparative, three-arm, parallel allocation, single-center clinical study to evaluate the effectiveness of Venusia CeraPlus cream and lotion as an adjuvant in the treatment of atopic dermatitis
- Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)*
- Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
- Outcome Measures in Cutaneous Autoimmune Disease: Dermatomyositis and Lupus Erythematosus
- Contents Vol. 4, 2018